CUR stock forecast
Our latest prediction for Neuralstem, Inc.'s stock price was made on the May 17, 2017 when the stock price was at 4.01$.
In the short term (2weeks), CUR's stock price should outperform the market by 5.90%. During that period the price should oscillate between -10.20% and +21.29%.
In the medium term (3months), CUR's stock price should outperform the market by 8.98%. During that period the price should oscillate between -22.41% and +52.81%.Get email alerts
About Neuralstem, Inc.
Neuralstem, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a loss of -0.50$ per share.
The book value per share is 0.41$
Three months stock forecastMay 17, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|